nitazoxanide has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, X; Fan, G; Gong, F; Huang, Y; Jia, K; Li, X; Lu, H; Shen, T; Wang, X; Xu, Z; Zhang, J | 1 |
| Alfandari, S; Bories, C; Boyle, EM; Caro, J; Cordier, C; Davies, FE; Demarquette, H; Demonchy, J; Escure, G; Facon, T; Faure, K; Fréalle, E; Herbaux, C; Morgan, G; Noel, MP; Van De Wyngaert, Z; Willaume, A | 1 |
2 other study(ies) available for nitazoxanide and Diathesis
| Article | Year |
|---|---|
Nitazoxanide induced myocardial injury in zebrafish embryos by activating oxidative stress response.
Topics: Animals; Animals, Genetically Modified; Apoptosis; Cardiotoxicity; Computational Biology; Disease Models, Animal; Disease Susceptibility; Embryo, Nonmammalian; Gene Expression Profiling; Gene Ontology; Heart Injuries; Myocytes, Cardiac; Nitro Compounds; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Thiazoles; Zebrafish | 2021 |
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma.
Topics: Antiparasitic Agents; Combined Modality Therapy; Cryptosporidiosis; Cryptosporidium; Diarrhea; Disease Management; Disease Susceptibility; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nitro Compounds; Retreatment; Symptom Assessment; Thiazoles; Tomography, X-Ray Computed; Treatment Outcome | 2021 |